A detailed history of Teacher Retirement System Of Texas transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 12,154 shares of SWTX stock, worth $402,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,154
Previous 10,424 16.6%
Holding current value
$402,175
Previous $513,000 10.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$36.06 - $47.62 $62,383 - $82,382
1,730 Added 16.6%
12,154 $458,000
Q1 2024

May 06, 2024

BUY
$36.5 - $52.5 $5,694 - $8,190
156 Added 1.52%
10,424 $513,000
Q4 2023

Feb 07, 2024

BUY
$18.94 - $37.24 $9,432 - $18,545
498 Added 5.1%
10,268 $375,000
Q3 2023

Oct 31, 2023

BUY
$23.12 - $31.38 $10,195 - $13,838
441 Added 4.73%
9,770 $226,000
Q2 2023

Jul 19, 2023

SELL
$23.15 - $32.71 $28,706 - $40,560
-1,240 Reduced 11.73%
9,329 $245,000
Q1 2023

May 12, 2023

BUY
$24.97 - $34.05 $59,553 - $81,209
2,385 Added 29.14%
10,569 $272,000
Q4 2022

Feb 10, 2023

SELL
$21.73 - $28.72 $15,493 - $20,477
-713 Reduced 8.01%
8,184 $213,000
Q3 2022

Nov 03, 2022

BUY
$24.1 - $39.66 $214,417 - $352,855
8,897 New
8,897 $254,000
Q2 2022

Aug 09, 2022

SELL
$18.36 - $60.07 $75,257 - $246,226
-4,099 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$48.97 - $65.46 $15,033 - $20,096
307 Added 8.1%
4,099 $231,000
Q4 2021

Feb 10, 2022

BUY
$53.3 - $75.84 $33,845 - $48,158
635 Added 20.11%
3,792 $235,000
Q3 2021

Nov 09, 2021

BUY
$62.66 - $88.26 $40,541 - $57,104
647 Added 25.78%
3,157 $200,000
Q2 2021

Aug 05, 2021

BUY
$67.45 - $85.63 $169,299 - $214,931
2,510 New
2,510 $207,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.06B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.